Patent litigation with Wyeth in which Merck Sharp & Dohme is seeking to revoke patents which cover Wyeth’s Prevnar 13 products (vaccines that reduce the incidence of severe ear infections in children, and pneumonia in the elderly). Wyeth has alleged infringement of these patents by the proposed launch of Merck Sharp & Dohme’s own 15-valent vaccine.